Skip Navigation



European Heart Journal Advance Access published online on October 13, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn451
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
29/21/2585    most recent
ehn451v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lip, G. Y.H.
Right arrow Articles by Butt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lip, G. Y.H.
Right arrow Articles by Butt, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Gender and the response to blood pressure-lowering treatment

Gregory Y.H. Lip* and Mehmood Butt

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK

* Corresponding author. Tel: +44 121 507 5080; Fax +44 121 507 5907, Email: g.y.h.lip@bham.ac.uk

This editorial refers to ‘Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials’{dagger} by F. Turnbull et al., on page 2669

The first 10% of the full text of this article appears below.

Hypertension is a global public health problem, making it one of the leading causes of cardiovascular morbidity and mortality.1,2 The management of hypertension can broadly be divided into the appropriate identification and cardiovascular risk stratification and, secondly, a holistic therapeutic strategy. Given the marked benefits of treating hypertension on complications such as stroke and myocardial infarction, it is no longer a question of ‘do we treat hypertension?’ but the more important questions in relation to hypertension treatment are ‘who to treat?. ... and ‘how to treat?’

We know that the prevalence of hypertension is extremely variable in various epidemiological regions of the world. Indeed, ethnic differences . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials
Fiona Turnbull, Mark Woodward, Bruce Neal, Federica Barzi, Toshiharu Ninomiya, John Chalmers, Vlado Perkovic, Nicole Li, S. MacMahon, and the Blood Pressure Lowering Treatment Trialists' Collaboration
EHJ 2008 29: 2669-2680. [Abstract] [FREE Full Text]